A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.
Carcinogenesis
; 34(7): 1529-35, 2013 Jul.
Article
in En
| MEDLINE
| ID: mdl-23486016
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polymorphism, Genetic
/
Thyroid Neoplasms
/
Interleukins
/
Promoter Regions, Genetic
/
Epithelial Cells
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Carcinogenesis
Year:
2013
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom